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For some oncologic emergencies, surgical interventions are necessary for dissolution or
temporary relieve. In the absence of guidelines, the most optimal method for decision mak-
ing would be in a multidisciplinary cancer conference (MCC). In an acute setting, the oppor-
tunity for multidisciplinary discussion is often not available. In this study, the management
and short term outcome of patients after surgical oncologic emergency consultation was
analyzed.
Method
A prospective registration and follow up of adult patients with surgical oncologic emergen-
cies between 01-11-2013 and 30-04-2014. The follow up period was 30 days.
Results
In total, 207 patients with surgical oncologic emergencies were included. Postoperative
wound infections, malignant obstruction, and clinical deterioration due to progressive dis-
ease were the most frequent conditions for surgical oncologic emergency consultation. Dur-
ing the follow up period, 40% of patients underwent surgery. The median number of
involved medical specialties was two. Only 30% of all patients were discussed in a MCC
within 30 days after emergency consultation, and only 41% of the patients who underwent
surgery were discussed in a MCC. For 79% of these patients, the surgical procedure was
performed before the MCC. Mortality within 30 days was 13%.
Conclusion
In most cases, surgery occurred without discussing the patient in a MCC, regardless of the
fact that multiple medical specialties were involved in the treatment process. There is a
need for prognostic aids and acute oncology pathways with structural multidisciplinary man-
agement. These will provide in faster institution of the most appropriate personalized cancer
care, and prevent unnecessary investigations or invasive therapy.
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Introduction
An oncologic emergency is an acute, potentially life threatening condition that has developed
directly or indirectly as a result of cancer or cancer treatment [1, 2]. Non-elective consultation
for symptoms caused by malignant disease is an important marker of poor prognosis [3–8].
For some oncologic emergencies, surgical interventions may be necessary for dissolution or
temporary relieve [9]. Not all cancer patients will benefit from surgery. A surgical intervention
is irreversible, and can result in severe complications. For patients with poor performance and/
or advanced disease, invasive treatment could have a detrimental impact on the life expectancy
and quality of life.
It is hardly possible to draught guidelines for the management of surgical oncologic emer-
gencies. The great inter-patient variability and an even greater variety of influencing factors re-
quire that every patient needs to be evaluated individually [9]. In the absence of these
guidelines, the most optimal method for objective evaluation and decision making would be
discussion in a multidisciplinary cancer conference (MCC) [10]. It is essential to define the
prognosis of both the emergency and the cancer stage, and taking into account the patient’s
performance score when deciding on the treatment [9, 11]. The most appropriate therapy is
the treatment that has clinical benefit, and does not reduce the quality of life. Decisions regard-
ing treatment in emergency situations are often not easy to make, and a multidisciplinary ap-
proach can provide in more solid arguments regarding the invasiveness of treatment. In an
acute setting, time is scarce and the opportunity for multidisciplinary discussion is often not
available. Decisions have to be made timely for prompt management of the emergency, and
thus are often made by a single specialist. Acute oncology teams and units have been intro-
duced for the care for patients with oncologic emergencies. These teams could prevent unnec-
essary investigations or therapy, and can provide in quick referral to palliative care when
necessary [12–17]. However, specialized acute oncology care is not widely implemented in
common medical practice.
In order to provide arguments for the future development of structural acute oncology path-
ways for faster institution of optimal care, it is important to be aware of (1) the occurrence of
(surgical) oncologic emergencies, (2) the decisional process and the amount of patients being
discussed in multidisciplinary cancer conferences, and (3) the clinical outcome of current man-
agement. In this study, the management and short term outcome of patients after surgical on-
cologic emergency consultation was analyzed.
Materials and Methods
A prospective registration and follow up was performed for adult cancer patients (age> 18) in
the University Medical Center Groningen (UMCG), who required consultation for surgical on-
cologic emergencies, between 01-11-2013 and 30-04-2014. The protocol was consistent with
the declaration of Helsinki of 1975, as revised in 1983, and approval for the study was retrieved
from the institutional Medical Ethics Committee of the University Medical Center Groningen.
Written informed consent was retrieved from participants, and all data were analyzed
anonymously.
Criteria for inclusion were: surgical oncologic emergency consultation for symptoms caused
by any type of malignant disease (including primary presentation), or for symptoms caused by
current or previous cancer treatment (surgery, radiation therapy, chemotherapy, drug targeted
therapy). When a surgical oncologist and/or surgical resident was involved in the diagnostic
and decisional process, and the possibility of surgical treatment had been evaluated, the consul-
tation was regarded as being a surgical oncologic emergency consultation. Patients who re-
quired emergency consultation for symptoms that could not be related to malignant disease or
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cancer treatment were excluded for analysis. This means that the entire hospital population
was studied, including patients who were initially admitted on other than surgical wards (e.g.
gynecology, internal medicine) and required surgical oncologic consultation.
Patients who required surgical emergency consultation through four possible pathways
were to meet the inclusion criteria: (1) presentation at the Emergency Room (ER), (2) non-elec-
tive admission through the (surgical) outpatient clinic, (3) transfer from other hospitals, and
(4) in-hospital request of surgical consultation for patients admitted for other specialties.
General patient characteristics were documented upon inclusion; gender, age, oncological
history, previous cancer treatment, disease status before the emergency consultation (not being
diagnosed with cancer, Alive With Disease—AWD, No Evidence of Disease—NED—after can-
cer treatment), intention of the current cancer treatment (diagnostic, curative, palliative). The
following variables were documented during the follow up: type of surgical oncologic emergen-
cy, type of treatment (i.e. surgical procedures or other interventions), number of involved med-
ical specialties during hospital admission, and whether the patient was discussed in a
Multidisciplinary Cancer Conference (MCC). In the UMCG, multiple regularly scheduled
MCC’s for different cancer types are integrated in common cancer care. In general, they in-
clude the disciplines that are involved in the diagnostic process and treatment according to the
prevailing guidelines. For this study, a patient was regarded as being discussed in a MCC when
a report of the MCC was documented in the patient’s chart.
The follow up period was 30 days. At final follow up, the patients’ charts were analyzed for
disease status (AWD, NED), intention of cancer treatment (curative, palliative) and mortality.
All data were processed through IBM SPSS Statistics 22 for statistical analysis.
Results
During the study period, 3737 patients had visited the ER for surgical consultation, and 402 of
these patients (11%) had a previous history of cancer, or active malignant disease. After visiting
the ER, 147 patients (4% of all 3737 patients, and 37% of the 402 cancer patients) were identi-
fied to have surgical oncologic emergencies and were included for analysis. The remaining pa-
tients visited the ER for non-oncologic issues.
Further, 19 cancer patients were non-electively admitted through the surgical outpatient
clinic for surgical oncologic emergencies, another 35 cancer patients required in-hospital surgi-
cal oncologic emergency consultation during admission for other medical specialties, and 6 pa-
tients were transferred from other hospitals.
In total, 207 patients with surgical oncologic emergencies were included for analysis through
all pathways. There were 101 (49%) males and 106 (51%) females, and median age was 64
(range 19–92) years. Of all patients, 21 patients had a primary presentation of malignant dis-
ease, 132 patients were alive with disease (AWD) that was previously diagnosed, and 54 pa-
tients had No Evidence of Disease (NED) after being treated for cancer in the past, of whom 9
patients presented with recurrent disease. Of the patients who had been diagnosed with cancer
in the past, the most prominent type of cancer was colorectal carcinoma (26%). Table 1 pro-
vides an extensive overview of the baseline characteristics for all 207 cancer patients with surgi-
cal oncologic emergencies.
Baseline characteristics of cancer patients who were consultated for
surgical oncologic emergencies
Obstruction (e.g. colorectal, biliary, small intestine), and infection were the most frequent con-
ditions for surgical oncologic emergency consultation (42% and 32% respectively) (Table 2).
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Table 1. Baseline characteristics of cancer patients who experienced surgical oncologic
emergencies.
Total n = 207
Male 101 (48.8)
Female 106 (51.2)















Weekend day 26 (12.6)
Weekend evening/night 20 (9.7)
Route consultation
Emergency Room 147 (71.0)
In-hospital consultation 35 (16.9)
Outpatient clinic 19 (9.2)
Transfer from other hospital 6 (2.9)
Cancer type
Colorectal carcinoma 54 (26.1)
Hepatobiliary 18 (8.7)
Breast cancer 14 (6.8)
Soft tissue sarcoma/GIST 14 (6.8)
Neuroendocrine tumor 13 (6.3)
Melanoma 11 (5.3)
Cervix carcinoma 8 (3.9)
Hematologic malignancy 8 (3.9)
Esophageal carcinoma 7 (3.4)
Non-melanoma skin cancer 6 (2.9)
Lung carcinoma 4 (1.9)
Prostate carcinoma 3 (1.4)
Ovarian carcinoma 3 (1.4)
Gastric carcinoma 2 (1.0)
Other 7 (3.4)
Unknown 14 (6.8)
No cancer 21 (10.1)
Other type of cancer
No 174 (84.1)
Yes 33 (15.9)
Time since cancer diagnosis
(Continued)
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After surgical oncologic emergency consultation at the ER, 109 of the 147 patients (74%)
were directly hospitalized. Four of the remaining 38 patients (11%) had an emergency admis-
sion within 30 days after the first consultation at the ER. Together with the patients who were
already hospitalized before the surgical oncologic emergency consultation (the patients who re-
quired in-hospital consultation or transfer from other hospitals), 173 of all patients with surgi-
cal oncologic emergencies (84%) had been hospitalized during the study period.
During hospitalization, the median number of radiologic, endoscopic, and surgical interven-
tions was 1 (range 0–09). Eighty three of all patients (40%) underwent surgery during the fol-
low up period. The median duration between inclusion and surgery was 38 hours (range 0–720
hours/30 days). Of these patients, 70 patients (84%) underwent surgery in an emergency setting
after a median period of 25.5 (range 0–720) hours, and 13 patients (16%) underwent elective
surgical procedures after a median period of 16 (range 7–30) days.
Table 1. (Continued)
Total n = 207
No cancer diagnosis before consultation 21 (10.1)
<30 days 26 (12.6)
30 days—6 months 56 (27.1)
6 months—1 year 20 (9.7)
1–2 years 13 (6.3)
2–5 years 41 (19.8)
> 5 years 30 (14.5)
Documented stage of treatment before surgical oncologic emergency consultation
No cancer 21 (10.2)
Active disease 129 (62.3)
Diagnostic stage 32 (15.5)
Receiving treatment with curative intent 49 (23.7)
Palliative stage 48 (23.2)
NED* after being treated for cancer in the past 57 (27.5)
< 30 days 19 (9.2)
30 days—6 months 10 (4.8)
6 months—1 year 7 (3.4)
1–2 years 6 (2.9)
2–5 years 6 (2.9)
> 5 years 9 (4.3)
Previous Radiotherapy 66 (31.9)
Previous Chemotherapy 72 (34.8)
Previous Surgery 126 (60.9)
Time since last cancer treatment
Continuously 24 (11.6)
< 30 days 62 (30.0)
30 days—6 months 32 (15.5)
6 months—1 year 9 (4.3)
1–2 years 15 (7.2)
2–5 years 5 (2.4)
> 5 years 12 (5.8)
No cancer treatment 48 (23.2)
* NED: No Evidence of Disease
doi:10.1371/journal.pone.0124641.t001
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Table 2. Diagnosis after surgical oncologic emergency consultation and 30 day follow up for surgical interventions, mortality, and discussion in a
multidisciplinary cancer conference (MCC) within the follow up period.
Classiﬁcation N Diagnose N Surgery Deceased MCC*
Obstruction 86 Malignant 62 38 (61.3) 8 (12.9) 26 (41.9)
Colorectal 22 16 (72.7) 3 (13.6) 11 (50.0)
Biliary 19 7 (36.8) 1 (5.3) 6 (31.6)
Small intestine 18 14 (77.8) 4 (22.2) 7 (38.9)
Airway 2 1 (50.0) - 2 (100)
Gastroesofageal 1 - 1 (100) -
Benign 24 10 (41.7) 1 (4.2) 4 (16.7)
Colorectal 8 1 (12.5) - 1 (12.5)
Small intestine 7 5 (71.4) 1 (14.3) 1 (14.3)
Radiation enteritis 4 4 (100) - 1 (25.0)
Biliary 3 - - 1 (33.3)
Gastroesofageal 1 - - -
Urinary 1 - - -
Infection 67 Postoperative wound infection 25 3 (12.0) 2 (8.0) 5 (20.0)
Score 1 or 2** 6 - - -
Score 3 or 4 17 2 (11.7) - 5 (29.4)




11 4 (36.4) 2 (18.2) -
Fistula formation after surgery 7 2 (28.6) - -
Intraabdominal infection after
surgery
7 1 (14.2) - 3 (42.9)
Infectious tumor mass 5 3 (60.0) 1 (20.0) 3 (60.0)
Wound healing disturbance after
radiation therapy and Surgery
4 1 (25.0) - -
Score 1 or 2** 3 1 (33.3) - -
Score 3 1 - - -
Chronic presacral absess
formation after pelvic surgery
and radiation therapy
3 - - 1 (33.3)
Postoperative gastroenteritis 3 - - -
Lymphedema/erysipelas 2 - - -
Clinical deterioration 19 Clinical deterioration due to
progressive metastatic disease
9 1 (11.1) 4 (44.4) 2 (22.2)
Clinical deterioration and pain
due to progressive tumor mass
8 3 (37.5) 3 (37.5) 4 (50.0)
Clinical deterioration being
NED***
2 - 1 (50.0) -
Gastrointestinal leak 12 Perforation in the presence of
tumor mass
7 6 (85.7) 3 (42.9) 1 (14.3)
Anastomotic leak after surgery 5 3 (60.0) - 2 (40.0)
Bleeding/thrombosis 12 Tumorbleeding 8 2 (25.0) - 3 (37.5)
Paraneoplastic arterial/venous
thrombosis
3 1 (33.3) - 1 (33.3)
Postoperative bleeding 1 1 (100) - 1 (100)
Pathological fracture 5 Fractures due to bone
metastases
5 3 (60.0) - 1 (20.0)
(Continued)
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The median number of involved medical specialties during admission was 2 (range 1–8).
Within 30 days after surgical oncologic emergency consultation, 61 patients (30%) were dis-
cussed in a MCC, after a median duration of 12 (range 1–30) days. For only 25 of these patients
(15% of all hospitalized patients, and 41% of all patients who were discussed), the MCC took
place while they were hospitalized after a median period of 8 (range 1–35) days after emergency
consultation. The remaining 36 patients were discussed in a MCC after discharge from the ER
or hospital ward. Of the 62 patients with symptoms caused by malignant obstruction, 42%
were discussed in a MCC (Table 2), and 61% of these patients underwent surgical treatment
during the follow up period. Gastrointestinal perforation in the presence of tumor mass (14%),
benign obstruction (17%), and postoperative wound infections (20%) were the diagnoses with
the lowest rates of multidisciplinary discussion.
Only 34 (41%) of the 83 patients who underwent surgery were discussed in a MCC during
the follow up period. For 27 of these 34 patients (79%), the surgical procedure was performed
before the MCC, and only 7 patients (21%) were discussed in a MCC prior to surgery. Regard-
ing the moment of surgery in relation to the moment of the MCC, the median period was 9
days prior to (range 26 days prior to—21 days after) the MCC (Fig 1).
Before surgical oncologic emergency consultation, 32 patients (16%) were in a diagnostic
and/or staging process, 49 patients (24%) received cancer treatment with curative intent, 57 pa-
tients (28%) had NED after being treated for cancer in the past, and 48 patients (23%) were di-
agnosed to have incurable malignant disease and were in a palliative stage of treatment.
Another 21 patients (10%) had no cancer diagnosis before surgical oncologic emergency con-
sultation, and had a primary presentation of malignant disease. At final follow up, 70 patients
(34%) received adjuvant treatment with curative intent or were scheduled for supplementary
curative surgical procedures, 42 patients (20%) were NED, and 69 patients (33%) were in a pal-
liative stage, and 26 patients (13%) were deceased.
Many of the patients who were in a palliative stage at final follow up had undergone surgery
after inclusion (52%), and 35% of all the patients who were deceased. Most patients died of pro-
gressive disease (77%) and 23% died of clinical sepsis or multiple organ failure. Of the deceased
patients, 12 (46%) died at home after the institution of palliative care, 10 (39%) died during
hospital admission, and 4 patients (15%) were transferred to a nursing home or hospice. Fig 2
visualizes the clinical pathway of the cancer patients in this study.
Discussion
To our knowledge, this is the first extensive analysis of surgical oncologic emergencies and the
management in clinical practice. For 37% of the cancer patients who had visited the ER, the
Table 2. (Continued)
Classiﬁcation N Diagnose N Surgery Deceased MCC*
Other 6 Lymphadenopathy/malignant
swelling
3 1 (33.3) - 1 (33.3)
Chylus leakage postoperative 2 - - 1 (50.0)
Incidental diagnosis on imaging
studies
1 - - 1 (100)
* MCC: Multidisciplinary Cancer Conference
** According to the Southampton Wound Assesment Scale
*** NED: No Evidence of Disease
doi:10.1371/journal.pone.0124641.t002
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surgical consultation at the ER was related to a surgical oncologic emergency. Surgeons will not
only be confronted with oncologic emergencies through the ER, but also through the outpa-
tient clinic, and in- or inter-hospital consultation. Almost a third of the patients in this cohort
were consultated through other pathways than the ER.
In the past decades, MCCs have become common practice, especially in elective oncology
care [18]. Cancer patients represent a complex population and often require treatment from
multiple medical specialties. In this study, only 30% of the patients who had been consultated
Fig 1. The timing of surgery in relation to the timing of the Multidisciplinary Cancer Conference (MCC). The MCC is set as timepoint 0.
doi:10.1371/journal.pone.0124641.g001
Fig 2. The 30-day clinical pathway of cancer patients after surgical oncologic emergency
consultation. Starting at stage of treatment prior to the consultation, whether patients undergo surgery and/
or are being discussed in a *Multidisciplinary Cancer Conference (MCC), and stage of treatment 30 days
after surgical oncologic emergency consultation.
doi:10.1371/journal.pone.0124641.g002
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for surgical oncologic emergencies had been discussed in a MCC within 30 days after emergen-
cy consultation. This is strikingly low, since the national and institutional guidelines require
that every cancer patient is discussed in a MCC to establish general agreement before the start
of cancer treatment. For all 33 patients the MCC took place at a regular weekly schedule, and
acute multidisciplinary discussion upon admission was not available. This means that for the
majority (79%) of the patients who were discussed, emergency treatment was instigated before
the MCC; for the 34 patients who underwent surgery and who had been discussed, there was a
median period of -9 days in relation to the MCC. The rate of patients being discussed in a
MCC was regardless of the amount of medical specialties that were involved during admission
(a median of 2 different specialties per patient).
These results confirm the outcome of other studies, that for the most cancer patients who
are non-electively treated for surgical oncologic emergencies, emergency (surgical) manage-
ment—or the decision to refrain from surgery—is performed without discussing the patient in
a MCC [10]. Physicians of different medical specialties, who are involved in the treatment pro-
cess of one patient, can have one-to-one transmissions regarding field specific issues of atten-
tion. Nevertheless, without discussing these issues in an organized group-setting, no overall
objective view will be obtained in order to connect all issues and transfer these into the same di-
rection of treatment. For patients who require emergency treatment,—non-scheduled—multi-
disciplinary evaluation by acute oncology experts should be available.
Obstruction is the most frequent oncologic emergency seen in surgical practice [9]. In this
study, of all patients with surgical oncologic emergencies, 42% had symptoms of obstruction
with either malignant or benign origin. Surgery often seems to be the best solution for relieve
of the obstruction, but could also have an adverse influence on the survival and quality of life.
Cancer stage and the performance status of the patient are the most important predictors of
survival, and the main factors to influence the successfulness of invasive therapies [11, 19–21].
Patients with obstruction of the gastrointestinal tract often require emergency surgery, and the
time frame until the next scheduled MCC will be too large. For all oncologic emergencies, eval-
uation of all treatment options is essential. Even if the consequences of the emergency are fatal-
ly, the quality of life remains the highest priority at the end of life. Only 42% of the 62 patients
with symptoms caused by malignant obstruction were discussed in a MCC. However, 61% of
all these patients underwent surgical treatment. Gastrointestinal perforation in the presence of
tumor mass, benign obstruction, and postoperative wound infections were the diagnoses of pa-
tients with the lowest rate of multidisciplinary discussion. The severity of diagnoses (wound in-
fection), and time (gastrointestinal perforation) are possibly factors that have had influence on
the different rates of multidisciplinary management.
The number of patients with poor outcome after surgical oncologic emergency consultation
was high. Within 30 days, 33% of patients had ended in a palliative stage and 13% were de-
ceased. Taken together, 46% of all patients had poor outcome on very short term. This was
twice as many compared to the 23% of patients who were already in a palliative (and thus
poor) stage before inclusion. Other studies have reported 30-day mortality rates of 10% and
30% after emergency abdominal surgery in cancer patients [11, 22]. The cohort of patients in
this study represents a more heterogeneous category, however, the 30-day mortality rate re-
mains high. Regardless of the outcome, many patients had undergone surgery. Of the patients
who ended in a palliative stage, 52% had undergone surgery during the study period, and 35%
of all the patients who were deceased.
Physicians have the tendency to overestimate the life expectancy of terminally ill cancer pa-
tients, and it is against the nature of many to spare someone from treatment [23–25]. An earlier
study by Ramchandran et al. tried to create a prediction model to identify hospitalized cancer
patients at risk for 30-day mortality, based on information only from the electronic medical
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record [26]. Patients’ performance scores were not included in the model, because it requires
clinical assessment of the patient. However, the performance score has been reported to be one
of the most important predictors of outcome [19–21, 27]. Further research to identify influenc-
ing factors, and the development of prognostic tools, is necessary for more accurate prediction
of outcome in the acute setting. Prognostic aids for decision making in a multidisciplinary set-
ting will contribute to argumentation for (refraining from) invasive therapies. Further, when
the expected outcome of therapies, or a near death, is communicated to the patient and family,
it can prevent disappointment after non-successful invasive treatment, and preserve the quality
of a patient’s life during the last stage [28, 29].
The heterogeneity of the common cancer patient population, and the variety of surgical on-
cologic emergencies is evident in this study. The interpatient variety (patient performance, can-
cer stage) is the cause of variable clinical outcome and impedes guidelines for management of
these emergencies. This heterogeneity is the core of the difficulties and dilemmas in clinical
(surgical) practice, and supports the need for the development of decision aids and acute oncol-
ogy pathways with structural multidisciplinary management.
Since this is an observational study, it is not possible to evaluate if the treatment of patients
with surgical oncologic emergencies would have been different when the decisional process
had involved a MCC. The reasons why some patients were discussed in a MCC and others
were not is not recorded in this study. For patients who were discussed and underwent surgical
procedures, the median time period of 9 days between surgery and a MCC implicates that at
this point the MCC’s are used for decision making after a pathology result is present, and not
for acute treatment decisions including surgery. Furthermore, the fact that, also for many pa-
tients who were not discussed in a MCC, multiple medical specialties were involved in the
treatment process, could reflect the complexity of pathology.
This study was performed in one tertiary university hospital, and comparison to other hos-
pitals will be difficult. However, since the patient population represents an entire hospital pop-
ulation, the authors believe that the results of the current study reflect common medical
practice. In most hospitals, patients with oncologic emergencies will present through the ER,
and specialized acute oncology care has not been implemented in standard emergency care.
The implementation of acute oncology pathways, providing systematic multidisciplinary
management of all patients, would be the most optimal way for decision making and treatment
of patients with oncologic emergencies [12–17]. Acute oncology care should include structural
availability of a specialized team of (at least) an emergency care specialist, a surgical oncologist,
a radiation oncologist, a medical oncologist, a palliative care specialist, and an oncology nurse.
This team will be trained in acute oncology care, and should be available throughout the day
and evening (in exclusive cases during the night). The members of this acute oncology team
need to be involved in the evaluation and treatment process directly after emergency presenta-
tion. In this way, non-scheduled multidisciplinary decision making will be possible and person-
alized treatment can be instituted on the shortest term, preventing delay of required therapies
or overtreatment.
Close involvement of the patient’s general practitioner is required during hospital admis-
sion. In this way, when invasive treatment is not expected to be favorable for the patient, pallia-
tive care can be instituted more efficiently and on shorter term. At the end of life, the length of
hospitalization should be limited to only what is needed for care with clinical benefit.
Further prospective research is necessary to investigate the influence of acute oncology
pathways and structural multidisciplinary management on the clinical outcome and quality
of life.
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Conclusions
Obstruction (i.e. colorectal, biliary, small intestine) and infection were the most frequent con-
ditions for surgical oncologic emergency consultation. Many patients ended in a palliative
stage, and the overall mortality within 30 days was 13%. In most cases, emergency treatment,
including invasive therapies such as surgery, occurred without discussing the patient in multi-
disciplinary cancer conferences, regardless of the fact that multiple medical specialties were in-
volved in the treatment process. There is a need for the development and evaluation of
prognostic aids and acute oncology pathways providing in structural multidisciplinary man-
agement. It will result in institution of the most appropriate personalized cancer care on the
shortest term, preventing delay of required therapies or overtreatment.
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